| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |